Global Wellness Apps

Technology , Healthcare
Toronto, Ontario, Canada
416 520 1660
Global Wellness Apps Inc.
Global Wellness Apps Inc.


Funded Of $75,000.00 Goal
4.67% Raised
Equity Crowdfunding Offer. Structure
05 Days Days Left
$200.00 Min. investment
$100,000.00 Max. investment
$75,000.00 Minimum Raise
$500,000.00 Maximum Raise

Offering Description

Top Reasons to Invest


We have market validation - over 17K registered Users

Our User base is focused on diabetes – a highly desired market that advertisers will pay premium to access

Our Marketplace unifies and engages our Users (similar to Facebook’s Marketplace)

DiaStrong Telehealth is uniquely positioned to provide laser focused care to those affected by diabetes or in a prediabetic state across North America

The Diabetic Exchange is positioned to become a popular mainstream show and the leading voice of the diabetic market

The Problem

To those affected, diabetes presents a 24/7 challenge filled with significant stress and ongoing requirements for support, information, products and services.

There is a lack of access to these requirements.


Our Solution Provides these Requirements

Massive Market Size (North America)



37+ million diabetics in North America**

96+ million prediabetics in North America**


The North American Diabetic Market is significantly increasing year-over-year.

*Sources: **CDC Centers for Disease Control and Prevention 2020 Report on Diabetes,

Dual Purposes


Revenue Generation

Advertising – charging premium rates to our hyper-segmented platform (100% of our User Base is diabetic relevant)

Marketplace – facilitating peer-to-peer sales of diabetic supplies to our hyper-segmented platform

Telehealth – to be available across North America and expected to generate ~25% net margins

Podcast & Radio – generating Advertising & Sponsorship Revenue and supporting the other Global Wellness Apps properties

Features Timeline


Diabetes Support & Management


Free-to-use & designed for all types of diabetes

Includes necessary tools and resources for improved diabetes management

Includes a peer-to-peer Marketplace

Revenue in the form of digital advertising

Ability to cross-market with DiaStrong and The Diabetic Exchange



Studies show that peer support and engagement improves diabetes self-management and the adoption of healthy behaviors.

Source: BMC (

Telehealth Platform


Provides North American wide personalized online healthcare for diabetics & prediabetics

Has significant monetization opportunities driven from The Diabetes App's captivated User Base

Expands our market reach into the prediabetic market which  is 2x the size of the diabetic market



Shoppers Drug Mart recently announced a $75 million investment Maple Telehealth a Canadian-only in exchange for a minority stake.

Podcast & Radio Platform


Presented by 2 hosts from polar oppositeperspectives to attract both T1 & T2 as well as a general audiences

Featuring a wide-ranging panel of guests such as healthcare practitioners, politicians, celebrities, interesting guests, etc.

Informational, entertaining, thought provoking and potentially controversial

Available on multiple media formats including Podcast, YouTube Channel (live and recorded) and Traditional Radio

Potential to become a mainstream show and a very popular content provider that is focused on the Diabetes Community



  • 140 million Americans listened to a podcast in August 2021 up from 32% in August 2019
  • 68 million Americans listen to podcasts weekly – up from 22% in 2019
  • 16 million Americans consider themselves “avid podcast fans”



User Testimonials


Growth Projections


Financial Position

  • Bootstrapped by Founder ~ $1M
  • Founder holds 85% / SPV holds 15% of current equity
  • Minimal Debt / Version 2 of platform substantially paid for 
  • Current Raise – 2.5M shares for $225K Net Proceeds ($10M Valuation)

Allocation of Net Proceeds:

Future Financial Plans

1st Quarter 2022 - $1M on a $15M Valuation*

2nd Quarter 2022- $3M on a $25M Valuation*

Contemporaneous with a direct listing on the CSE, with a cross listing on the US OTC and the Frankfurt Exchange

*Subject to applicable market conditions

Long Term Plans

Continue to build our User/Patient/Listener base, expand revenues and resulting profitability, execute on effective strategies to maximize shareholder value & dominate the Diabetic Market.


NOTE: You will need your Bank Account Number, Transit Number, and Institution Number to Invest.

Pre-money valuation (before investment received): ~$8,200,000

Minimum Raise: $75,000.00 for 750,000 Common Shares for 0.86%% at $0.10 per Common Share.

Max Raise: $500,000 for 5,000,000 Common Shares for 5.74% at $0.10 per Common Share.  

Securities offered: Common, Voting Shares

Note: Please review attached 45-110 Offering Document for full details on the offer.  You can also review the attached Articles of Incorporation, Shareholder's Agreement,  and Corporate By-Laws for details on the rights of the shares being purchased.

Management Team

Sean Zaboroski

Sean Zaboroski

Co-Founder, CEO Director

(MBA/LLB) an experienced and successful entrepreneur.

Read More
Taylor Companion

Taylor Companion

Co-Founder COO

An experienced operations manager with altruistic enterprises.

Read More
Ruri Otani

Ruri Otani

Co-Founder CRO

An experienced revenue manager.

Read More
Stuart Hensman

Stuart Hensman

Independent Director

Former Director, Chairman, CEO & Managing Director (Equities) for Scotia Capital Inc. (US and UK) 

Read More
John Papastergiou

John Papastergiou


Pharmacist, assistant professor, internationally recognized speaker, author and appointed to the Ontario Pharmacist Research Collaboration in 2014.

Read More
Project launched


No Q&A have been posted for this campaign yet. Ask the project creator directly.